Drug intelligence / Profile preview

selcopintide

Development stage
Phase 2
Lead developer
HysensBio
Modality
Peptides
Administration
Topical
01

Overview

**Selcopintide** is a synthetic 10-amino acid peptide (sequence: K.Y.K.Q.K.R.R.S.Y.K) derived from the 344-353 fragment of human Copine7 (CPNE7) protein, developed for dentin hypersensitivity and periodontal regeneration. It mimics CPNE7's role in odontoblast differentiation by binding to nucleolin on pre-odontoblast cells, facilitating internalization, nuclear translocation, and upregulation of odontoblast marker genes such as dentin sialophosphoprotein (DSPP) and Nestin, leading to dentin formation and mineralization. Preclinical studies in human dental pulp cells, mouse pre-odontoblasts, and beagle dog models demonstrated dose-dependent gene upregulation, mineralization, and regeneration of dentin, periodontal ligament, cementum, and bone; a phase 1/2a first-in-human trial showed significant reduction in dentin hypersensitivity (VAS decrease of -23.2 mm at 10 µg/tooth, p<0.05) with excellent safety (no serious AEs, no systemic absorption).[1][2][9][10]

Other names
selcopintide
02

Targets

NCL (Nucleolin)

Beyond the preview

Go deeper on selcopintide.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on selcopintide.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call